Pharmerica (PMC) Tops Q3 EPS by 3c

Pharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04